SUZHOU, China, Sept. 5, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma," HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced today that the company\'s stock has been included in the Hong Kong...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]connect-program-301369597.html